By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ardelyx Inc. 

34175 Ardenwood Boulevard
Suite 100
Fremont  California  94555  U.S.A.
Phone: 510-745-1700 Fax: n/a


Company News
Ardelyx Inc. (ARDX) Appoints Jeremy S. Caldwell, Ph.D., As Executive Vice President And Chief Scientific Officer 12/1/2014 4:02:58 PM
Ardelyx Inc. (ARDX)'s Tenapanor Reduces Phosphorus Absorption And Protects Against Vascular Calcification In Preclinical In Vivo Model Of Chronic Kidney Disease 11/17/2014 3:26:38 PM
Ardelyx Inc. (ARDX) Reports Third Quarter 2014 Financial Results 11/6/2014 8:57:39 AM
Ardelyx Inc. (ARDX) To Report Third Quarter 2014 Financial Results On November 6, 2014 10/30/2014 9:36:19 AM
Ardelyx Inc. (ARDX)'s Tenapanor Selected For Oral And Poster Presentations At The American Society of Nephrology's Kidney Week 2014 10/23/2014 11:04:58 AM
Ardelyx Inc. (ARDX) Looks Good After Tenanpanor Results: Citi Analysts 10/1/2014 3:14:37 PM
Ardelyx Inc. (ARDX) Irritable Bowel Syndrome Drug Succeeds In Phase 2b Trial 10/1/2014 6:01:51 AM
Ardelyx Inc. (ARDX) Chief Scientific Officer, Dominique Charmot, Announces Retirement From The Company At Year-End 9/5/2014 9:50:39 AM
Ardelyx Inc. (ARDX) To Present At The Wedbush 2014 Life Sciences Management Access Conference 8/5/2014 9:31:07 AM
Ardelyx Inc. (ARDX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/25/2014 6:20:40 AM